Oxycodone (Oxycodone Amneal) 5 mg tablets: Supply issue

Supply issue Active

Due to shipping delays, there is a supply issue affecting the 5 mg immediate release oxycodone tablets.

Affected product

Due to shipping delays, there is a supply issue affecting:  

  • Chemical: Oxycodone hydrochloride
  • Presentation: Tab immediate-release 5 mg
  • Brand: Oxycodone Amneal
  • Pharmacode: 2681919 and 2696053
  • Subsidy: $13.77
  • Measure / Qty: per 100

Schedule listing for oxycodone(external link)

Unaffected products

Currently, there are no concerns for the other strengths, oral liquid, or the controlled-release capsules. 

Alternative product

The 10 mg immediate release tablet has a score line and the Datasheet indicates that the tablet can be halved. The oral liquid (1 mg / ml) is also available. Rule 3.4.2 applies for funding, however a new prescription may be needed to meet requirements of the Misuse of Drugs Regulations.

Prescribers may also want to consider prescribing an alternative analgesic.

We acknowledge that this will cause create disruption for those affected. We have developed a flyer to support conversations with people affected by this supply issue.

Expected resupply

The next shipment is due in mid-to-late March 2025. It will take another 1 to 2 weeks to reach pharmacies around the motu.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.  

Sign up to our email list for regular emails about supply issues and more(external link)